# Biomarkers of Clopidogrel Resistance for Predicting Ischemic Recurrence After Cerebral Artery Stenting

> **NCT07028775** · — · NOT_YET_RECRUITING · sponsor: **Nanjing First Hospital, Nanjing Medical University** · enrollment: 839 (estimated)

## Conditions studied

- Ischemic Stroke

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07028775
- **Lead sponsor:** Nanjing First Hospital, Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06
- **Primary completion:** 2027-04
- **Final completion:** 2027-04
- **Target enrollment:** 839 (ESTIMATED)
- **Last updated:** 2025-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07028775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07028775, "Biomarkers of Clopidogrel Resistance for Predicting Ischemic Recurrence After Cerebral Artery Stenting". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07028775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*